O12.5. EFFICACY AND SAFETY OF SEP-363856, A NOVEL PSYCHOTROPIC AGENT WITH A NON-D2 MECHANISM OF ACTION, IN THE TREATMENT OF SCHIZOPHRENIA: A 4-WEEK, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
O12.5. EFFICACY AND SAFETY OF SEP-363856, A NOVEL PSYCHOTROPIC AGENT WITH A NON-D2 MECHANISM OF ACTION, IN THE TREATMENT OF SCHIZOPHRENIA: A 4-WEEK, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started